HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area.

Abstract
The comparative efficacy of albendazole and mebendazole in the treatment of intestinal nematode infections were compared 3 weeks after treatment in a randomized trial among schoolchildren on Pemba Island, Tanzania. Egg counts were compared 3 weeks, 4 months and 6 months after treatment of 731 children seen on each occasion. Differences in the efficacies were apparent with some nematodes 21 d after treatment, but these were no longer apparent 4 months after treatment, and by 6 months intensities of infection were similar to pre-treatment levels. These findings suggest that treatment of schoolchildren every 4 months may be necessary in this highly endemic area in order to have an impact on the intensity of intestinal nematode infections sufficient to be likely to reduce morbidity.
AuthorsM Albonico, P G Smith, E Ercole, A Hall, H M Chwaya, K S Alawi, L Savioli
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1995 Sep-Oct Vol. 89 Issue 5 Pg. 538-41 ISSN: 0035-9203 [Print] England
PMID8560535 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antinematodal Agents
  • Mebendazole
  • Albendazole
Topics
  • Albendazole (therapeutic use)
  • Antinematodal Agents (therapeutic use)
  • Ascariasis (drug therapy)
  • Child
  • Feces (parasitology)
  • Hookworm Infections (drug therapy)
  • Humans
  • Intestinal Diseases, Parasitic (drug therapy)
  • Mebendazole (therapeutic use)
  • Parasite Egg Count
  • Recurrence
  • Sampling Studies
  • Tanzania
  • Time Factors
  • Treatment Outcome
  • Trichuriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: